Publicaciones en colaboración con investigadores/as de University of Amsterdam (10)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 10, pp. 2910-2921

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2022

  1. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

    Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121

2019

  1. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): A harmonised study protocol for two phase i clinical trials comparing intradermal and intranodal cell administration

    BMJ Open, Vol. 9, Núm. 9

2018

  1. MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

    Hepatology, Vol. 67, Núm. 4, pp. 1420-1440

2015

  1. Lack of TAFI increases brain damage and microparticle generation after thrombolytic therapy in ischemic stroke

    Thrombosis Research, Vol. 136, Núm. 2, pp. 445-450

2012

  1. Design of modified U1i molecules against HIV-1 RNA

    Antiviral Research, Vol. 94, Núm. 3, pp. 208-216

2009

  1. Ae2a,b-deficient mice exhibit osteopetrosis of long bones but not of calvaria

    FASEB Journal, Vol. 23, Núm. 10, pp. 3470-3481

2008

  1. In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-β1

    Journal of Immunology, Vol. 181, Núm. 1, pp. 126-135